Navigation Links
Former Sanofi-aventis and US Oncology Executive Joins New Century Health as Chief Executive Officer
Date:1/16/2012

BREA, Calif., Jan. 16, 2012 /PRNewswire/ -- New Century Health announced today that its board of directors has appointed Atul Dhir, M.D., Ph.D., chief executive officer.  Dr. Dhir will spearhead the national expansion of New Century Health's specialty care management services focused on oncology and cardiology.  Water Street Healthcare Partners, a strategic private equity firm focused exclusively on health care that invested in New Century Health last year, recruited Dr. Dhir to the position.

(Logo: http://photos.prnewswire.com/prnh/20120116/CG35564LOGO)

Dr. Dhir joins New Century Health from his position as CEO of BiPar Sciences, Inc., a Sanofi-aventis biotech subsidiary that develops new cancer drugs.  He previously served as a senior executive with US Oncology, the largest provider of cancer care in the United States.  During his 10 years with the company, Dr. Dhir led several businesses, including the company's Cancer Research Group, one of the nation's leading cancer drug development companies.  Dr. Dhir has also held senior positions in the health care division of Monsanto Company and at McKinsey & Company.

"Dr. Dhir possesses a rare combination of deep scientific expertise and years of operational experience. He has an impressive 20-year history of leading and growing highly specialized health care businesses focused on transforming care," said Steve Cosler, chairman of New Century Health and an operating partner with Water Street.  "Dr. Dhir clearly stood out as the leader best suited to building on New Century's strong foundation to expand its services to payers and providers across the country."

Dr. Dhir has advised numerous health care organizations and currently serves on the advisory boards of several health care companies.  He completed his doctorate of philosophy in molecular biology from the University of Oxford, where he studied as a Rhodes Scholar.  He received his medical degree from the All India Institute of Medical Sciences in New Delhi, India. 

"My career has been dedicated to leading innovative organizations that are committed to improving health care on a large scale.  New Century Health has a unique and collaborative approach to improving the quality of patient care, while reducing the administrative work and overall costs of medical care in cancer, cardiology and other specialties.  I am excited to lead and grow the company to deliver these urgently needed services to patients, payers and providers across the country," said Dr. Dhir.

Dr. Dhir assumes the CEO position immediately.

 

About New Century Health

New Century Health is a national specialty care management company that provides innovative technology and clinical solutions to enhance the quality of patient care, while reducing the administrative work and improving the cost efficiency associated with the delivery of care.  Its customers include both payers and doctors providing specialty care services to members of Medicare, Medicaid and commercial payers. New Century Health is a company of Water Street, a strategic private equity firm focused exclusively on health care. New Century Health is an official licensee of the NCCN Drugs & Biologics Compendium™. To learn more about New Century Health, visit www.NewCenturyHealth.com.

 

 


'/>"/>
SOURCE New Century Health
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Former Speaker of the House Newt Gingrich Featured Wednesday
2. Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe
3. Former Cables to Go/Lastar Inc. Employee's Move to Form American Consumer Cables Pays Off
4. Dynamic Signs Asset Acquisition Deal With Cannex and Brings Onboard Leading Medical Cannabis Research Scientist Dr. Robert Melamede, Former Chairman of the Biology Department, University of Colorado
5. Former Telomolecular CEO Clarifies SEC Settlement
6. Shire Successfully Settles Former TKT Shareholder Appraisal Rights Litigation
7. Former NASDAQ International President Among Execs Launching Firm to Access Global Markets
8. Kendle Reappoints Former CFO Timothy M. Mooney to Board of Directors
9. Cynvec LLC(SM) Appoints Former Johnson & Johnson Executive Frank D. Stonebanks as President and Chief Executive Officer
10. Cyntellect Appoints Former BD Biosciences Executive Andre Lubarsky as Director of Sales - North America
11. Cyntellect Appoints Former Millipore and BD Biosciences Executives to Head Up its Product Marketing Efforts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2016)... Baltimore, MD (PRWEB) , ... May 20, 2016 , ... ... contaminated with Listeria, as reported by Food Safety News on May 12, 2016(1), demonstrates ... according to Ted Olsen, CEO of Baltimore-based biotech firm, PathSensors, Inc. ...
(Date:5/19/2016)... SAN DIEGO , May 19, 2016 /PRNewswire/ ... (OTCBB: RGBP), (OTC PINK: RGBP) and (OTC PINK: RGBPP) announced ... at creating the first cord blood based cancer ... a provisional patent application, Regen described a generation ... activity was potentiated by gene silencing.  The product ...
(Date:5/18/2016)... ... May 18, 2016 , ... STACS DNA Inc., the sample tracking software ... report sexual assault kit processing to help them save time and reduce errors. , ... kits to be processed and victims informed of results. Due to a previous lack ...
(Date:5/17/2016)... McKinney, Texas (PRWEB) , ... May 17, 2016 ... ... product for use in animal waste reduction applications, announced today it will be ... Des Moines, Iowa. , ManureMagicâ„¢ was featured in the Wall Street Journal last ...
Breaking Biology Technology:
(Date:4/26/2016)... Research and Markets has announced ... 2016-2020"  report to their offering.  , ,     (Logo: ... analysts forecast the global multimodal biometrics market to ... period 2016-2020.  Multimodal biometrics is being ... the healthcare, BFSI, transportation, automotive, and government for ...
(Date:4/15/2016)... 15, 2016  A new partnership announced today ... underwriting decisions in a fraction of the time ... and high-value life insurance policies to consumers without ... With Force Diagnostics, rapid testing (A1C, Cotinine and ... (blood pressure, weight, pulse, BMI, and activity data) ...
(Date:4/14/2016)... 14, 2016 BioCatch ™, ... today announced the appointment of Eyal Goldwerger ... Goldwerger,s leadership appointment comes at a time ... the deployment of its platform at several of the ... which discerns unique cognitive and physiological factors, is a ...
Breaking Biology News(10 mins):